Dark

Check out our API

ENDV
NDONOVO THERAPEUTICS INC
stock OTC

EOD

Aug 7, 2026

0.000050USD+4900.000%(+0.000049)1,399,999

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Oct 12, 2021

04:05PM EDT High-Growth Acquisition Approaches Completion, Expected To Augment Core Business And Drive Long-Term Shareholder Value GlobeNewswire Inc

May 11, 2021

08:00AM EDT Stanford University Orthopedic Study Collaboration with Endonovo GlobeNewswire Inc

Oct 8, 2020

08:00AM EDT Endonovo Therapeutics Offers FDA Cleared GlobeNewswire Inc

Sep 9, 2020

08:00AM EDT Endonovo Therapeutics Announces Encore Live Webinar of Baylor GlobeNewswire Inc

Aug 20, 2020

02:52PM EDT Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced financial and operating results for the second quarter ended June 30, 2020. GlobeNewswire Inc

Jul 27, 2020

09:00AM EDT Endonovo Therapeutics Announces Significant Results From Study GlobeNewswire Inc

Jul 21, 2020

09:00AM EDT Endonovo Therapeutics Announces Effectiveness of Registration of GlobeNewswire Inc

Share